Ugo di Francesco
Direttore/Membro del Consiglio presso LABOMAR S.P.A.
Posizioni attive di Ugo di Francesco
Società | Posizione | Inizio | Fine |
---|---|---|---|
LABOMAR S.P.A. | Direttore/Membro del Consiglio | - | - |
Chiesi Ltd.
Chiesi Ltd. Electronic Equipment/InstrumentsElectronic Technology Chiesi Ltd. develops and markets respiratory products. It offers medicines for the treatment of respiratory disease. The company was founded on June 18, 1987 and is headquartered in Manchester, the United Kingdom. | Direttore/Membro del Consiglio | 06/03/2012 | - |
Chiesi SA (Belgium)
Chiesi SA (Belgium) Pharmaceuticals: MajorHealth Technology Part of Valline Srl, Chiesi SA (Belgium) is a Belgian pharmaceutical company specializing in the treatment of respiratory diseases, neonatology, rare diseases, and special care. Chiesi SA (Belgium is based in Machelen, BE. The company's focus on innovation and patient care has led to collaborations with other organizations, such as Affibody, and the development of new treatments for rare diseases. Chiesi SA (Belgium is committed to sustainability and participates in events such as Climbing for Life. The company was founded in 2010 by Giacomo Chiesi, and the CEO is Alberto Chiesi. | Direttore/Membro del Consiglio | - | - |
International Federation of Pharmaceutical Manufacturers
International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | Corporate Officer/Principal | - | - |
Farmindustria SA
Farmindustria SA Pharmaceuticals: MajorHealth Technology Farmindustria SA engages in the development, manufacture, and commercialization of pharmaceutical products. These include anti-ulcers, multivitamins, anti-inflammatories, muscle relaxants, neurotonics, and calcium supplements. Its brands include Bonil, Caditar, Flectadol, Hiperflex, Maxucal, Trilat, and Ulcemex. The company was founded in March 1995 and is headquartered in Lima, Peru. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Ugo di Francesco
Precedenti posizioni note di Ugo di Francesco
Società | Posizione | Inizio | Fine |
---|---|---|---|
Sigma-Tau Industrie Farmaceutiche Riunite SpA
Sigma-Tau Industrie Farmaceutiche Riunite SpA Pharmaceuticals: MajorHealth Technology Sigma-Tau Industrie Farmaceutiche Riunite SpA engages in the provision of biopharmacological research and technology development services. It offers pharmaceutical products for therapeutic areas, such as cardiology and metabolism, gastroenterology, infectious diseases, urology, rheumatology, osteoporosis, neurology, psychiatry, and oncology. The company was founded by Emilio Cavazza and Claudio Cavazza in 1957 and is headquartered in Rome, Italy. | Amministratore Delegato | 19/05/2010 | 01/01/2011 |
AMGEN INC. | Corporate Officer/Principal | - | - |
Novartis Consumer Health SpA
Novartis Consumer Health SpA Pharmaceuticals: OtherHealth Technology Part of Novartis AG, Novartis Consumer Health SpA is an Italian company that manufactures and distributes medical drugs. The company is based in Origgio, Italy. | Amministratore Delegato | - | - |
Novartis sro | Corporate Officer/Principal | - | - |
░░░░░░░░░░░░░ ░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░ ░░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | - |
Statistiche
Distribuzione geografica
Italia | 6 |
Regno Unito | 2 |
Belgio | 2 |
Posizioni
Director/Board Member | 5 |
Corporate Officer/Principal | 4 |
Chief Executive Officer | 3 |
Settori
Health Technology | 10 |
Electronic Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 2 |
---|---|
LABOMAR S.P.A. | Health Technology |
AMGEN INC. | Health Technology |
Aziende private | 9 |
---|---|
Sigma-Tau Industrie Farmaceutiche Riunite SpA
Sigma-Tau Industrie Farmaceutiche Riunite SpA Pharmaceuticals: MajorHealth Technology Sigma-Tau Industrie Farmaceutiche Riunite SpA engages in the provision of biopharmacological research and technology development services. It offers pharmaceutical products for therapeutic areas, such as cardiology and metabolism, gastroenterology, infectious diseases, urology, rheumatology, osteoporosis, neurology, psychiatry, and oncology. The company was founded by Emilio Cavazza and Claudio Cavazza in 1957 and is headquartered in Rome, Italy. | Health Technology |
CHIESI Farmaceutici SpA
CHIESI Farmaceutici SpA Pharmaceuticals: MajorHealth Technology Chiesi Farmaceutici SpA develops and markets pharmaceutical products. The firm specializes in research, development and production of drugs in respiratory dosage forms, such as metered-dose inhalers and sterile unit dose vials. The company was founded by Giacomo Chiesi in 1935 and is headquartered in Parma, Italy. | Health Technology |
Chiesi Ltd.
Chiesi Ltd. Electronic Equipment/InstrumentsElectronic Technology Chiesi Ltd. develops and markets respiratory products. It offers medicines for the treatment of respiratory disease. The company was founded on June 18, 1987 and is headquartered in Manchester, the United Kingdom. | Electronic Technology |
Chiesi SA (Belgium)
Chiesi SA (Belgium) Pharmaceuticals: MajorHealth Technology Part of Valline Srl, Chiesi SA (Belgium) is a Belgian pharmaceutical company specializing in the treatment of respiratory diseases, neonatology, rare diseases, and special care. Chiesi SA (Belgium is based in Machelen, BE. The company's focus on innovation and patient care has led to collaborations with other organizations, such as Affibody, and the development of new treatments for rare diseases. Chiesi SA (Belgium is committed to sustainability and participates in events such as Climbing for Life. The company was founded in 2010 by Giacomo Chiesi, and the CEO is Alberto Chiesi. | Health Technology |
Bristol-Myers Squibb SRL
Bristol-Myers Squibb SRL Pharmaceuticals: MajorHealth Technology Bristol-Myers Squibb SRL develops, manufactures and supplies pharmaceuticals. It offers diabetes, oncology, cardiovascular, neuroscience, virology, and immunology services. The company is headquartered in Rome, Italy. | Health Technology |
Novartis sro | |
Novartis Consumer Health SpA
Novartis Consumer Health SpA Pharmaceuticals: OtherHealth Technology Part of Novartis AG, Novartis Consumer Health SpA is an Italian company that manufactures and distributes medical drugs. The company is based in Origgio, Italy. | Health Technology |
International Federation of Pharmaceutical Manufacturers
International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | Health Technology |
Farmindustria SA
Farmindustria SA Pharmaceuticals: MajorHealth Technology Farmindustria SA engages in the development, manufacture, and commercialization of pharmaceutical products. These include anti-ulcers, multivitamins, anti-inflammatories, muscle relaxants, neurotonics, and calcium supplements. Its brands include Bonil, Caditar, Flectadol, Hiperflex, Maxucal, Trilat, and Ulcemex. The company was founded in March 1995 and is headquartered in Lima, Peru. | Health Technology |
- Borsa valori
- Insiders
- Ugo di Francesco
- Esperienza